535-0310-00L  Glycobiology in Drug Development

SemesterHerbstsemester 2021
DozierendeV. I. Otto
Periodizitätjährlich wiederkehrende Veranstaltung
LehrspracheEnglisch



Lehrveranstaltungen

NummerTitelUmfangDozierende
535-0310-00 VGlycobiology in Drug Development1 Std.
Mi/113:45-15:30HIL E 8 »
V. I. Otto

Katalogdaten

KurzbeschreibungProtein-based drugs constitute around 25% of new approvals and most of them are glycoproteins. Using selected examples of prominent glycoprotein drugs, the course aims at providing insight into glycosylation-activity relationships and into biotechnological production and analytics.
LernzielStudents gain basic knowledge in "pharmaceutical glycobiology". This implies knowing and understanding:
- major mechanisms underlying the roles of glycosylation for the biological/therapeutic actions of glycoproteins (glycosylation-function relationships) using prominent examples of glycoprotein drugs.
- the major types of protein-linked glycans and the biosynthetic pathways for their formation
- how glycoprotein drugs are produced (including the most important expression systems used), glycoengineered and analysed (quality control).
Students are able to apply this knowledge in solving simple problems in glycoprotein drug development (on paper).
Students gain the ability to reflect on roles of glycosylation in various biological contexts.
Inhaltlecture plan:
1. Glycans - information carriers in biology and pharmacotherapy
2. Glucocerebrosidase and the biosynthesis of N-glycans
3. Improving the therapeutic profile of monoclonal antibodies by glycoengineering
4. Mucin-type O-glycans and sialylation as gCQA of glycoprotein hormone drugs
5. production and gCQA analysis of Glucocerebrosidase, monoclonal antibodies, glycoprotein hormone drugs - Glycoanalytics
6. EPO "the same but different"
SkriptThe slides used for the lectures will be provided online
Literatur- Essentials of Glycobiology 3rd edition, A. Varki, R.D. Cummings et al., Cold Spring Harbor Laboratory Press, New York 2017.
- recent publications as cited/proposed on the lecture slides
Voraussetzungen / BesonderesRequirements: Basic knowledge in immunology, molecular biology, protein and carbohydrate chemistry, analytical techniques. Basic knowledge in pharmacology.
KompetenzenKompetenzen
Fachspezifische KompetenzenKonzepte und Theoriengeprüft
Verfahren und Technologiengeprüft
Methodenspezifische KompetenzenAnalytische Kompetenzengeprüft
Problemlösunggeprüft
Soziale KompetenzenKommunikationgeprüft
Persönliche KompetenzenKreatives Denkengeprüft
Kritisches Denkengeprüft

Leistungskontrolle

Information zur Leistungskontrolle (gültig bis die Lerneinheit neu gelesen wird)
Leistungskontrolle als Semesterkurs
ECTS Kreditpunkte1 KP
PrüfendeV. I. Otto
Formbenotete Semesterleistung
PrüfungsspracheEnglisch
RepetitionRepetition ohne erneute Belegung der Lerneinheit möglich.
ZulassungsbedingungRegular attendance of the lessons and answering the take home questions related to each lesson is highly recommended.
The lecture slides are designed to illustrate what is explained and discussed during the lessons.
Zusatzinformation zum PrüfungsmodusA statement or question regarding the main topics of the course has to be discussed / answered in the form of an essay (700-1000 words written in English, German, French or Italian). The assay will be reviewed and graded.

At a later time point to be agreed upon by lecturer and students, the essays and their contents will be discussed.

Lernmaterialien

Keine öffentlichen Lernmaterialien verfügbar.
Es werden nur die öffentlichen Lernmaterialien aufgeführt.

Gruppen

Keine Informationen zu Gruppen vorhanden.

Einschränkungen

Keine zusätzlichen Belegungseinschränkungen vorhanden.

Angeboten in

StudiengangBereichTyp
Humanmedizin BachelorKompensationsfächerWInformation
Pharmaceutical Sciences MasterWahlfächer IWInformation
Pharmazeutische Wissenschaften BachelorKompensationsfächerWInformation
Pharmazie MasterWahlfächerWInformation